Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Understand the rationale behind cash back rewards on credit cards. Learn how to take advantage of these offers.
26,130 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
In May, Grail stock surged on optimism about FDA approval timing and potential reimbursement for the Galleri MCED tes...
When a company executive moves tens of thousands of shares, it sparks questions. This guide explains what insider sel...
A quiet, multi-layered shield sits between enterprises and danger. This article explains the invisible layer protecti...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
SpaceX kicked off trading with a sharp first-day rally. This guide analyzes historical IPO patterns to estimate where...
Software stocks bounce Nvidia falters as investors rotate from AI-chip names to durable software franchises, signalin...
Tesla is steering its $25 billion capex plan beyond cars and into AI and robotics. This shift could transform margins...
In 2026, Part B premiums surged to $202.90 as Social Security COLA lagged, highlighting medicare premium growth often...
In the demanding world of entertainment and performance, schedules are harsh and pay can be unpredictable. This artic...
One large investor dumped 783,379 Truth Social shares, triggering a sharp move in the stock. This article explains wh...
Analysts see strong demand for Nvidia's AI hardware and software ecosystem. This piece breaks down why great news NVI...